Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fixed Dose Rate Gemcitabine in Advanced Colorectal Cancer
NCT00220155Phase 2Completed
- Sponsor
- Royal Marsden NHS Foundation Trust
- Start
- May 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine in colorectal cancer (CRC), sponsored by Royal Marsden NHS Foundation Trust. Started May 2004; status: completed.
02
Drugs
gemcitabine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00220155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00220155.